[Table/Fig-5]:
Antibiotic | Type of sensitivity | Strong biofilm | Average biofilm | Weak biofilm |
---|---|---|---|---|
Imipenem | Resistant | 32% | 35% | 23.2% |
Intermediate | 1% | 0% | 0% | |
Sensitive | 4.9% | 1% | 2.9% | |
Meropenem | Resistant | %35 | 0% | 23.3% |
Intermediate | 0% | 35% | 0% | |
Sensitive | 2.9% | 1% | 2.9% | |
Cefepime | Resistant | 32% | 35% | 21.4% |
Intermediate | 0% | 1% | 1% | |
Sensitive | 5.8% | 0% | 3.9% | |
Piperacillin | Resistant | 31.1% | 31.1% | 18.4% |
Intermediate | 1% | 0% | 4.2% | |
Sensitive | 5.8% | 4.9% | 2.9% | |
Ceftazidime | Resistant | 31.1% | 34% | 22.3% |
Intermediate | 3.9% | 0% | 2.9% | |
Sensitive | 2.9% | 1.9% | %1 | |
Ceftriaxone | Resistant | 29.1% | 32% | 21.4% |
Intermediate | 3.9% | 1.9% | 1.9% | |
Sensitive | 4.9% | 1.9% | 2.9% | |
Tazobactam | Resistant | 30.1% | 34% | 18.4% |
Intermediate | 1% | 0% | 0% | |
Sensitive | 6.8% | 1.9% | 7.8% | |
Ampicillin/sulbactam | Resistant | 16.5% | 7.8% | 3.2% |
Intermediate | 1% | 25.2% | %1 | |
Sensitive | 20.4% | 2.9% | 21.4% | |
Clavulanic acid-tazobactam | Resistant | 29.1% | 31.1% | 18.4% |
Intermediate | 1% | 0% | 1.9% | |
Sensitive | 7.8% | 4.9% | 5.8% | |
Colistin | Resistant | 1.9% | 1.9% | 6.8% |
Intermediate | 0% | 0% | 0% | |
Sensitive | 35% | 34% | 19.4% |